Press ReleasesPress ReleasesPress Releases May 2, 2025 PYKUS THERAPEUTICS ANNOUNCES POSITIVE INTERIM PILOT CLINICAL TRIAL RESULTS OF PYK-2101, A NOVEL RETINAL SEALANT April 10, 2025 PYKUS THERAPEUTICS COMPLETES TRIAL ENROLLMENT FOR PYK-2101, A NOVEL RETINAL SEALANT FOR THE TREATMENT FOR RETINAL DETACHMENT March 13, 2025 PYKUS THERAPEUTICS SELECTED TO PRESENT AT THE EURETINA SPECIAL FOCUS MEETING ON OCULAR ENDOTAMPONADES IN ATHENS, GREECE February 26, 2025 PYKUS THERAPEUTICS EXPANDS PATENT PORTFOLIO FOR PYK-2101, A FIRST-IN-CLASS RETINAL SEALANT DELIVERY TECHNOLOGY February 6, 2025 PYKUS THERAPEUTICS TO PRESENT INITIAL CLINICAL DATA ON PYK-2101, A NOVEL RETINAL SEALANT, AT THE VAIL VITRECTOMY 2025 MEETING Subscribe to our alerts and email notifications. * indicates required Email Address *
